Tekho Marine Biotech Balance Sheet Health
Financial Health criteria checks 4/6
Tekho Marine Biotech has a total shareholder equity of NT$87.1M and total debt of NT$60.2M, which brings its debt-to-equity ratio to 69.1%. Its total assets and total liabilities are NT$151.4M and NT$64.3M respectively.
Key information
69.1%
Debt to equity ratio
NT$60.21m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$9.36m |
| Equity | NT$87.09m |
| Total liabilities | NT$64.27m |
| Total assets | NT$151.36m |
Financial Position Analysis
Short Term Liabilities: 8465's short term assets (NT$35.1M) do not cover its short term liabilities (NT$44.8M).
Long Term Liabilities: 8465's short term assets (NT$35.1M) exceed its long term liabilities (NT$19.5M).
Debt to Equity History and Analysis
Debt Level: 8465's net debt to equity ratio (58.4%) is considered high.
Reducing Debt: 8465's debt to equity ratio has reduced from 87.8% to 69.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 8465 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 8465 has sufficient cash runway for 2.3 years if free cash flow continues to grow at historical rates of 43.1% each year.